The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Multinuclear Magnetic Resonance Spectroscopy Studies of Brain Purines in Major Depression
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This pattern has been shown to be beneficial for anti-depressant treatment [80]”
From Creatine supplementation in women's health: a lifespan perspective (2021) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Executive Dysfunction and Long-term Outcomes of Geriatric Depression
Alexopoulos, G. S., Meyers, B. S., Young, R. C., Kalayam, B., Kakuma, T., Gabrielle, M., Sirey, J. A., & Hull, J. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.3.285 · Cited by 486
Executive dysfunction predicts nonresponse to fluoxetine in major depression
Dunkin, J. J., Leuchter, A. F., Cook, I. A., Kasl-Godley, J. E., Abrams, M., & Rosenberg-Thompson, S. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00157-3 · Cited by 221
Research works printed but not linked: 29
- Drevets WC: Functional neuroimaging studies of depression: the anatomy of melancholia. Ann Rev Med 1998; 49:341-361 · DOI · Paper page
- Kennedy S, Javanmard M, Vaccarino F: A review of functional neuroimaging in mood disorders: positron emission tomography and depression. Can J Psychiatry 1997; 42:467-475 · DOI
- Moore CM, Christensen JD, Lafer B, Fava M, Renshaw PF: Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am J Psychiatry 1997; 154:116-118 · DOI
- Volz HP, Rzanny R, Riehemann S, May S, Hegwald H, Preussler B, Hubner G, Kaiser WA, Sauer H: 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur Arch Psychiatry Clin Neurosci 1998; 248:289-295 · DOI · Paper page
- Pissarek M, Garcia de Arriba S, Schafer M, Sieler D, Nieber K, Illes P: Changes by short-term hypoxia in the membrane properties of pyramidal cells and the levels of purine and pyrimidine nucleotides in slices of rat neocortex: effects of agonists and antagonists of ATP-dependent potassium channels. Naunyn Schmiedebergs Arch Pharmacol 1998; 358:430-439 · DOI
- Younkin D: Magnetic resonance spectroscopy in hypoxia-ischemia encephalopathy. Clin Invest Med 1993; 16:115-121
- Christensen JD, Kaufman MJ, Levin JM, Mendelson JH, Holman BL, Cohen BM, Renshaw PF: Abnormal cerebral metabolism in polydrug abusers during early withdrawal: a 31P MR spectroscopy study. Magn Reson Med 1996; 35:658-663 · DOI
- Deicken RF, Calabrese G, Merrin EL, Fein G, Weiner MW: Basal ganglia phosphorous metabolism in chronic schizophrenia. Am J Psychiatry 1995; 152:126-129 · DOI
- Buchsbaum M, Hazlett E: Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophr Bull 1998; 24:343-364 · DOI
- Volkow N, Wang G, Fowler J: Imaging studies of cocaine in the human brain and studies of the cocaine addict. Ann NY Acad Sci 1997; 820:41-54 · DOI
- Rauch SL, Renshaw PF: Clinical neuroimaging in psychiatry. Harv Rev Psychiatry 1995; 2:297-312 · DOI
- Decanniere C, Eleff S, Davis D, van Zijl PC: Correlation of rapid changes in the average water diffusion constant and the concentrations of lactate and ATP breakdown products during global ischemia in cat brain. Magn Reson Med 1995; 34:343-352 · DOI
- Mori S, Eleff SM, Pilatus U, Mori N, van Zijl PC: Proton NMR spectroscopy of solvent-saturable resonances: a new approach to study pH effects in situ. Magn Reson Med 1998; 40:36-42 · DOI
- van Zijl PC, Moonen CT: In situ changes in purine nucleotide and N-acetyl concentrations upon inducing global ischemia in cat brain. Magn Reson Med 1993; 29:381-385 · DOI
- Renshaw PF, Lafer B, Babb SM, Fava M, Stoll AL, Christensen JD, Moore CM, Yurgelun-Todd DA, Bonello CM, Pillay SS, Rothschild AJ, Nierenberg AA, Rosenbaum JF, Cohen BM: Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1997; 41:837-843 · DOI
- Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62 · DOI · Paper page
- Fleiss J, Cohen J, Everitt B: Large sample standard errors of kappa and weighted kappa. Psychol Bull 1969; 72:323-327 · DOI · Paper page
- Miller B, Chang L, Booth R, Ernst T, Cornford M, Nikas D, McBride D, Jenden D: In vivo 1H MRS choline: correlation with in vitro chemistry/histology. Life Sci 1996; 58:1929-1935 · DOI · Paper page
- Zheng J, Ramirez VD: Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Na+, K+ -ATPase of porcine cortex. Eur J Pharmacol 1999; 368:95-102 · DOI
- Horvat A, Petrovic S, Nedeljkovic N, Martinovic JV, Nikezic G: Estradiol affect Na-dependent Ca2+ efflux from synaptosomal mitochondria. Gen Physiol Biophys 2000; 19:59-71
- Too CK, Giles A, Wilkinson M: Estrogen stimulates expression of adenine nucleotide translocator ANT1 messenger RNA in female rat hearts. Mol Cell Endocrinol 1999; 150:161-167 · DOI
- Starkov AA, Simonyan RA, Dedukhova VI, Mansurova SE, Palamarchuk LA, Skulachev VP: Regulation of the energy coupling in mitochondria by some steroid and thyroid hormones. Biochim Biophys Acta 1997; 1318:173-183 · DOI
- Riehemann S, Volz HP, Wenda B, Hubner G, Rossger G, Rzanny R, Sauer H: Frontal lobe in vivo (31)P-MRS reveals gender differences in healthy controls, not in schizophrenics. NMR Biomed 1999; 12:483-489 · DOI
- Fava M, Giannelli A, Rapisarda V, Patralia A, Guaraldi GP: Rapidity of onset of the antidepressant effect of parenteral S-adenosyl-l-methionine. Psychiatry Res 1995; 56:295-297 · DOI
- Masand PS, Gupta S: Selective serotonin-reuptake inhibitors: an update. Harv Rev Psychiatry 1999; 7:69-84 · DOI
- Okada M, Kawata Y, Murakami T, Wada K, Mizuno K, Kondo T, Kaneko S: Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin. Eur J Neurosci 1999; 11:1-9 · DOI
- Anderson G, Hall L, Horne W, Yang J: Adenosine diphosphate inhibits the serotonin transporter. Biochim Biophys Acta 1996; 1283:14-20 · DOI
- Duman R: Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 1998; 44:324-335 · DOI
- Hetherington HP, Spencer DD, Vaughan JT, Pan JW: Quantitative (31)P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP. Magn Reson Med 2001; 45:46-52 · DOI
Cited by
Glutamate Metabolism in Major Depressive Disorder
Abdallah, C. G., Jiang, L., De Feyter, H. M., Fasula, M., Krystal, J. H., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010067 · Cited by 200
Adenosine, caffeine, and sleep–wake regulation: state of the science and perspectives
Reichert, C. F., Deboer, T., & Landolt, H. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13597 · Cited by 183
“…may be important (Gass et al., 2010; Pierling et al., 2021), female depressed patients who responded to the serotonin-reuptake inhibitor fluoxetine, also exhibited 30% lower brain ATP levels as quantified with magnetic resonance spectroscopy than treatment nonresponders (Renshaw et al., 2001).”
BackgroundAntidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling
Hines, D. J., Schmitt, L. I., Hines, R. M., Moss, S. J., & Haydon, P. G. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.136 · Cited by 160
Lyoo, I. K., Kong, S. W., Sung, S. M., Hirashima, F., Parow, A., Hennen, J., Cohen, B. M., & Renshaw, P. F. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(03)00046-5 · Cited by 140
Self-citationDietary creatine intake and depression risk among U.S. adults
Bakian, A. V., Huber, R. S., Scholl, L., Renshaw, P. F., & Kondo, D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0741-x · Cited by 90
Creatine supplementation in women's health: a lifespan perspective
Smith-Ryan, A. E., Cabre, H. E., Eckerson, J. M., & Candow, D. G. (2021) · Nutrients · doi:10.3390/nu13030877 · Cited by 92
Kondo, D. G., Forrest, L. N., Shi, X., Sung, Y.-H., Hellem, T. L., Huber, R. S., & Renshaw, P. F. (2016) · Amino Acids · doi:10.1007/s00726-016-2194-3 · Cited by 79
Self-citationCreatine for the Treatment of Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019) · Biomolecules · doi:10.3390/biom9090406 · Cited by 74
“[132] found that, although basal ganglia [β-NTP] and total purine levels did not differ between depressed subjects and healthy controls overall in their sample, in the subgroup of depressed subjects who responded to fluoxetine, [β-NTP] were 21% lower.”
Self-citationYoon, S., Kim, J. E., Hwang, J., Kim, T.-S., Kang, H. J., Namgung, E., Ban, S., Oh, S., Yang, J., Renshaw, P. F., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.027 · Cited by 71
Self-citationCreatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study
Hellem, T. L., Sung, Y.-H., Shi, X.-F., Pett, M. A., Latendresse, G., Morgan, J., Huber, R. S., Kuykendall, D., Lundberg, K. J., & Renshaw, P. F. (2015) · Journal of Dual Diagnosis · doi:10.1080/15504263.2015.1100471 · Cited by 49
Self-citationToniolo, R. A., Silva, M., Fernandes, F. D. B. F., Amaral, J. A. D. M. S., Dias, R. D. S., & Lafer, B. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1817-5 · Cited by 50
Silveri, M. M., Parow, A. M., Villafuerte, R. A., Damico, K. E., Goren, J., Stoll, A. L., Cohen, B. M., & Renshaw, P. F. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00064-7 · Cited by 35
Lyoo, I. K., Demopulos, C. M., Hirashima, F., Ahn, K. H., & Renshaw, P. F. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00041.x · Cited by 33
A potential role for creatine in drug abuse?
D’Anci, K. E., Allen, P. J., & Kanarek, R. B. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8176-2 · Cited by 9
Metadata
- Authors
- Renshaw, P. F., Parow, A. M., Hirashima, F., Ke, Y., Moore, C. M., Frederick, B. D., Fava, M., Hennen, J., & Cohen, B. M.
- Venue
- American Journal of Psychiatry
- Published
- 2001-12-01
- Volume
- 158
- Issue
- 12
- Pages
- 2048-2055
- ISSN
- 0002-953X
- 1535-7228
- Cited by
- 101
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
